Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC Academic Article uri icon

Overview

MeSH Major

  • Anilides
  • Carcinoma, Basal Cell
  • Pyridines
  • Skin Neoplasms

abstract

  • The 12-month update of the study confirms the efficacy and safety of vismodegib in management of advanced BCC.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jaad.2015.03.021

PubMed ID

  • 25981002

Additional Document Info

start page

  • 1021

end page

  • 6.e8

volume

  • 72

number

  • 6